SynthesisFrontiers in endocrinology2026
Glucagon-like peptide-1 receptor agonists and the risk of Parkinson's disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data.
Ying Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.